metabolic dysfuction-associated steatotic liver disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) outpatient or hospitalized patients with MASLD, non-NAFLD liver disease, or without liver disease 2) patients who are scheduled to undergo an upper endoscopy for medical purposes within 3 months 3) patients who are able to take dietary questionnaires, duodenal biopsies, and intestinal permeability tests 4) patients giving voluntary written informed concent after sufficient explanation for participation in this study
Exclusion criteria
Exclusion criteria: 1) Patients with abnormalities that are presumed to affect intestinal permeability, such as intestinal inflammation 2) Patients with a history of gastrointestinal surgery other than cholecystectomy or appendectomy 3) Patients with gastrointestinal malignancies 4) Patients with obvious bleeding tendencies or blood clotting abnormalities 5) Other patients who are judged to be inappropriate by the principal investigator or the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| fructose intake, length of duodenal villi, and small intestinal permeability | — |
Countries
Japan
Contacts
Tokai University School of Medicine Internal Medicine (gastroenterology)